CDC, USDA Complete Investigation Into Burkholderia pseudomallei Exposure at Tulane Research Center

Article

Officials from the Centers for Disease Control and Prevention (CDC), along with the U.S. Department of Agriculture's (USDA) Animal and Plant Health Inspection Service (APHIS), have completed their joint investigation into how the Burkholderia pseudomallei bacteria may have been inadvertently transferred from a secure, select agent laboratory into animals from the breeding colony of the Tulane National Primate Research Center (TNPRC). Although the specific transmission event has not been identified, plausible mechanisms were uncovered during the investigation.

CDC and APHIS inspectors identified lapses in the appropriate use of personal protective equipment; specifically, the correct use of outer wear to prevent contamination of clothing beneath them, which could have led to the bacteria clinging to inner garments and getting carried out of the select agent lab where research was being conducted with the bacteria on mice. The bacteria could have been transferred this way to the breeding colony where the non-human primates resided and/or to the clinic where routine examinations and treatments were administered. Additionally, CDC and APHIS inspectors determined that Tulane primate center staff frequently entered the select agent lab without appropriate protective clothing, which would increase the risk of bringing the bacteria out of the lab or becoming infected themselves.

Since Feb. 11, 2015, all select agent research at the Tulane primate facility has been suspended and will remain so until Tulane officials demonstrate satisfactorily to CDC and APHIS inspectors that:
- Entity-wide procedures exist to ensure animals accidentally exposed in the future are managed appropriately;
- All personal protective equipment procedures are thoroughly reviewed and revised appropriately to lessen the risk of future breaches;
- All Tulane primate center personnel are trained on any new or revised protective clothing procedures; and
- Improved entry and exit procedures to the outside enclosures housing non-human primates are in place to stop any further transmission among the animals.

The investigation was initiated when two primates at the Tulane center were diagnosed with Melioidosis (Whitmore's Disease), a bacterial illness of animals and humans more commonly diagnosed in tropical areas of the world and not found in North America. CDC laboratory analysis completed in mid-January determined that the strain of bacteria that sickened the non-human primates was identical to the one being used in research at the Tulane center.  The lab results led CDC and APHIS officials to determine the bacteria, a Tier 1 select agent regulated for research, was not contained.

CDC has found no evidence to date to suggest the organism was released into the surrounding environment and therefore it's unlikely there is any threat to the general population.

Burkholderia pseudomallei is not transmitted between humans or animals, and the risk of acquiring Melioidosis is low.  At this time, none of those workers at greatest risk of exposure or those whose blood samples indicated weakly reactive antibody levels have gotten sick.

CDC will continue to support USDA/APHIS and the U.S. Environmental Protection Agency with their investigations in the Tulane primate breeding colony to ensure the health of the center's employees and the community.

For more information about Melioidosis, visit http://www.cdc.gov/melioidosis/index.html.

Related Videos
Jill Holdsworth, MS, CIC, FAPIC, CRCST, NREMT, CHL
Jill Holdsworth, MS, CIC, FAPIC, CRCSR, NREMT, CHL, and Katie Belski, BSHCA, CRCST, CHL, CIS
Baby visiting a pediatric facility  (Adobe Stock 448959249 by Rawpixel.com)
Antimicrobial Resistance (Adobe Stock unknown)
Anne Meneghetti, MD, speaking with Infection Control Today
Patient Safety: Infection Control Today's Trending Topic for March
Infection Control Today® (ICT®) talks with John Kimsey, vice president of processing optimization and customer success for Steris.
Picture at AORN’s International Surgical Conference & Expo 2024
Infection Control Today and Contagion are collaborating for Rare Disease Month.
Related Content